Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 100 points on Friday. Investors, meanwhile, focused on some notable insider trades.
纳斯达克100指数周五收盘上涨超过100点。与此同时，投资者们关注了一些著名的内部交易。
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
当内部人士出售股份时，可能是预先计划好的卖出，也可能表明他们对公司前景的担忧，或者认为股票价格过高。内部人士的卖出不应被视为制定投资或交易决策的唯一指标。充其量，它可以加强卖出决策的信心。
Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.
以下是最近一些值得注意的内部交易。了解更多，请查看Benzinga的内部交易平台。
DICK'S Sporting Goods
迪克体育用品
- The Trade: DICK'S Sporting Goods, Inc. (NYSE:DKS) Director Desiree Ralls-Morrison sold a total of 3,489 shares at an average price of $206.65. The insider received around $721,002 from selling those shares.
- What's Happening: On May 29, Dick's Sporting Goods reported better-than-expected first-quarter FY24 earnings and raised the outlook.
- What DICK'S Sporting Goods Does: Dick's Sporting Goods retails athletic apparel, footwear, and equipment for sports.
- 交易：纽交所迪克体育用品股份有限公司（DKS）董事Desiree Ralls-Morrison以平均价格206.65美元出售了共计3489股。内部人士从出售这些股份中获得了大约721,002美元的收益。
- 正在发生的事情：5月29日，迪克体育用品公布了超出预期的2024财年第一季度收益，并提高了前景。
- 迪克体育用品主要零售体育运动服装、鞋类和器材。
Have a look at our premarket coverage here
在此查看我们的盘前报道
Regeneron Pharmaceuticals
再生元制药公司
- The Trade: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP General Counsel and Secretary Joseph J Larosa sold a total of 1,866 shares at an average price of $1,088.95. The insider received around $2.03 million from selling those shares.
- What's Happening: On July 11, Morgan Stanley analyst Matthew Harrison maintained Regeneron Pharmaceuticals with an Overweight and lowered the price target from $1,183 to $1,182.
- What Regeneron Pharmaceuticals Does: Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.
- 交易：纳斯达克再生元制药股份有限公司（REGN）执行副总裁兼秘书Joseph J Larosa以平均价格1088.95美元出售了共计1866股。内部人士从出售这些股份中获得了大约203万美元的收益。
- 正在发生的事情：7月11日，摩根士丹利分析师Matthew Harrison维持对再生元制药的股票推荐为“买入”，但将价格目标从1183美元下调至1182美元。
- 再生元制药公司的主要业务是开发和商业化对抗眼疾、心血管疾病、癌症和炎症的产品。
SMART Global Holdings
智能环球控股
- The Trade: SMART Global Holdings, Inc. (NASDAQ:SGH) President, LED Solutions Joseph Gates Clark sold a total of 5,000 shares at an average price of $29.00. The insider received around $145,006 from selling those shares.
- What's Happening: On July 9, SMART Global reported better-than-expected third-quarter financial results.
- What SMART Global Does: SMART Global Holdings Inc is a designer and manufacturer of electronic products focused on memory and computing technology areas.
- 交易：纳斯达克智能环球控股股份有限公司（SGH）LED解决方案总裁Joseph Gates Clark以平均价格29.00美元出售了共计5000股。内部人士从出售这些股份中获得了大约145,006美元的收益。
- 正在发生的事情：7月9日，智能环球公布了超出预期的第三季度财务业绩。
- 智能环球控股公司是一家电子产品设计和制造公司，专注于存储和计算技术领域。
Moderna
Moderna
- The Trade: Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan sold a total of 15,000 shares at an average price of $117.08. The insider received around $1.8 million from selling those shares.
- What's Happening: Moderna is expected to report its second quarter financial results on Thursday, Aug. 1.
- What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
- 交易：纳斯达克Moderna股份有限公司（MRNA）董事Noubar Afeyan以平均价格117.08美元出售了共计15000股。内部人士从出售这些股份中获得了大约180万美元的收益。
- 正在发生的事情：Moderna预计于8月1日星期四公布其第二季度财务业绩。
- Moderna是一家商业化生物科技公司，成立于2010年，于2018年12月首次公开募股。
- How To Earn $500 A Month From Bank of America Stock Ahead Of Q2 Earnings
- 如何在美国银行股份二季度收益发布前每月赚取500美元